We bring you the latest news from the healthcare about the health care in the United Kingdom.

vrijdag 26 oktober 2018

British Journal of Cancer - Table of Contents alert Volume  119 Issue 8

British Journal of Cancer


Explore the latest science, research, and clinical trials in hematology and oncology.


Volume 119, Issue 8

In this issue
Brief Communication
Brief Communication
Also new


Combination VEGFR/immune checkpoint inhibitor therapy: a promising new treatment for renal cell carcinoma

Chung-Han Lee & Robert Motzer

British Journal of Cancer 2018 119 :911 - 912; October 17, 2018; 10.1038/s41416-018-0175-x

Abstract | Full Text

Moving the needle on colorectal cancer genetics: it takes more than two to TANGO

Luis G. Carvajal-Carmona

British Journal of Cancer 2018 119 :913 - 914; October 04, 2018; 10.1038/s41416-018-0219-2

Abstract | Full Text


D-dimer and high-sensitivity C-reactive protein levels to predict venous thromboembolism recurrence after discontinuation of anticoagulation for cancer-associated thrombosis

Luis Jara-Palomares, Aurora Solier-Lopez, Teresa Elias-Hernandez, Maria Isabel Asensio-Cruz, Isabel Blasco-Esquivias et al.

British Journal of Cancer 2018 119 :915 - 921; October 15, 2018; 10.1038/s41416-018-0269-5

Abstract | Full Text

Target-based therapeutic matching of phase I trials in patients with metastatic breast cancer in a tertiary referral centre

Brent O’Carrigan, Joline Si Jing Lim, Awais Jalil, Samuel John Harris, Dionysis Papadatos-Pastos et al.

British Journal of Cancer 2018 119 :922 - 927; October 15, 2018; 10.1038/s41416-018-0290-8

Abstract | Full Text

Phase 1 study of ARQ 761, a β-lapachone analogue that promotes NQO1-mediated programmed cancer cell necrosis

David E. Gerber, M. Shaalan Beg, Farjana Fattah, Arthur E. Frankel, Oluwatomilade Fatunde et al.

British Journal of Cancer 2018 119 :928 - 936; October 15, 2018; 10.1038/s41416-018-0278-4

Abstract | Full Text

Brief Communication

Time to progression ratio in cancer patients enrolled in early phase clinical trials: time for new guidelines?

Sarah Watson, Jessica Menis, Capucine Baldini, Patricia Martin-Romano, Jean-Marie Michot et al.

British Journal of Cancer 2018 119 :937 - 939; October 17, 2018; 10.1038/s41416-018-0245-0

Abstract | Full Text


An IL13Rα2 peptide exhibits therapeutic activity against metastatic colorectal cancer

Rubén A. Bartolomé, Marta Jaén & J. Ignacio Casal

British Journal of Cancer 2018 119 :940 - 949; October 15, 2018; 10.1038/s41416-018-0259-7

Abstract | Full Text

Prognostic and predictive role of CD8 and PD-L1 determination in lung tumor tissue of patients under anti-PD-1 therapy

Jean-David Fumet, Corentin Richard, Fanny Ledys, Quentin Klopfenstein, Philippe Joubert et al.

British Journal of Cancer 2018 119 :950 - 960; October 15, 2018; 10.1038/s41416-018-0220-9

Abstract | Full Text

CD24 regulates cancer stem cell (CSC)-like traits and a panel of CSC-related molecules serves as a non-invasive urinary biomarker for the detection of bladder cancer

Akira Ooki, Christopher J. VandenBussche, Max Kates, Noah M. Hahn, Andres Matoso et al.

British Journal of Cancer 2018 119 :961 - 970; October 17, 2018; 10.1038/s41416-018-0291-7

Abstract | Full Text

Colon-specific eQTL analysis to inform on functional SNPs

Victor Moreno, M. Henar Alonso, Adrià Closa, Xavier Vallés, Anna Diez-Villanueva et al.

British Journal of Cancer 2018 119 :971 - 977; October 04, 2018; 10.1038/s41416-018-0018-9

Abstract | Full Text

Primary constitutional MLH1 epimutations: a focal epigenetic event

Estela Dámaso, Adela Castillejo, María del Mar Arias, Julia Canet-Hermida, Matilde Navarro et al.

British Journal of Cancer 2018 119 :978 - 987; October 04, 2018; 10.1038/s41416-018-0019-8

Abstract | Full Text

Genome-wide scan of the effect of common nsSNPs on colorectal cancer survival outcome

Evropi Theodoratou, Susan M Farrington, Maria Timofeeva, Farhat VN Din, Victoria Svinti et al.

British Journal of Cancer 2018 119 :988 - 993; August 21, 2018; 10.1038/s41416-018-0117-7

Abstract | Full Text

Mutant p53 blocks SESN1/AMPK/PGC-1α/UCP2 axis increasing mitochondrial O· production in cancer cells

Marco Cordani, Giovanna Butera, Ilaria Dando, Margalida Torrens-Mas, Elena Butturini et al.

British Journal of Cancer 2018 119 :994 - 1008; October 15, 2018; 10.1038/s41416-018-0288-2

Abstract | Full Text

Mice deficient in the mitochondrial branched-chain aminotransferase (BCATm) respond with delayed tumour growth to a challenge with EL-4 lymphoma

Elitsa A. Ananieva, Joshua N. Bostic, Ashley A. Torres, Hannah R. Glanz, Sean M. McNitt et al.

British Journal of Cancer 2018 119 :1009 - 1017; October 15, 2018; 10.1038/s41416-018-0283-7

Abstract | Full Text

Waist circumference and risk of 23 site-specific cancers: a population-based cohort study of Korean adults

Kyu Rae Lee, Mi Hae Seo, Kyung Do Han, Jinhyung Jung & In Cheol Hwang

British Journal of Cancer 2018 119 :1018 - 1027; October 17, 2018; 10.1038/s41416-018-0214-7

Abstract | Full Text

Maternal exposure to gasoline and exhaust increases the risk of childhood leukaemia in offspring – a prospective study in the Norwegian Mother and Child Cohort Study

Jorunn Kirkeleit, Trond Riise, Tone Bjørge, David C. Christiani, Magne Bråtveit et al.

British Journal of Cancer 2018 119 :1028 - 1035; October 15, 2018; 10.1038/s41416-018-0295-3

Abstract | Full Text

Brief Communication

The added value of genetic information in colorectal cancer risk prediction models: development and evaluation in the UK Biobank prospective cohort study

Todd Smith, Marc J. Gunter, Ioanna Tzoulaki & David C. Muller

British Journal of Cancer 2018 119 :1036 - 1039; October 16, 2018; 10.1038/s41416-018-0282-8

Abstract | Full Text

Nature Briefing is an essential round-up of science news, opinion and analysis, free in your inbox every weekday. With Nature Briefing, we'll keep you updated on the latest research, so you can focus on yours.

Click here to sign up.
nature events
Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here.

Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com
More Nature Events

Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to British Journal of Cancer. In order to do so, please purchase a subscription.

Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to British Journal of Cancer. In order to do so, please purchase a subscription.

This email has been sent to dezorgsector.uk@gmail.com.

If you no longer wish to receive the email alerts from British Journal of Cancer click here to unsubscribe .
If you wish to discontinue all email services from Nature Research please click here to unsubscribe .

For further technical assistance, please contact our registration department.

For print subscription enquiries, please contact our subscription department.

For other enquiries, please contact our customer feedback department.

Macmillan Publishers Limited is a company incorporated in England & Wales under company number 785998 & whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW. Nature Research | One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA

Nature is part of Springer Nature. © 2018 Springer Nature Limited. All rights reserved.

Springer Nature